SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    José Félix Martí Massó, Juan José Zarranz, David Otaegui, Adolfo López de Munain, Neurogenetic Disorders in the Basque Population, Annals of Human Genetics, 2015, 79, 1
  2. 2
    Andreas Puschmann, Zbigniew K. Wszolek, Movement Disorders, 2015,

    CrossRef

  3. 3
    Beatriz Alvarez-Castelao, Ana Gorostidi, Javier Ruíz-Martínez, Adolfo López de Munain, José G. Castaño, Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  4. 4
    Rakel Lopez de Maturana, Julio C. Aguila, Amaya Sousa, Nerea Vazquez, Patricia del Rio, Ana Aiastui, Ana Gorostidi, Adolfo Lopez de Munain, Rosario Sanchez-Pernaute, Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease, Neurobiology of Aging, 2014, 35, 5, 1116

    CrossRef

  5. 5
    Javier Ruiz-Martínez, Patricia de la Riva, Maria C. Rodríguez-Oroz, Elisabet Mondragón Rezola, Alberto Bergareche, Ana Gorostidi, Belen Gago, Ainara Estanga, Nerea Larrañaga, Cristina Sarasqueta, Adolfo López de Munain, José F. Martí Massó, Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2, Movement Disorders, 2014, 29, 6
  6. 6
    Rabah M. Shawky, Reduced penetrance in human inherited disease, Egyptian Journal of Medical Human Genetics, 2014, 15, 2, 103

    CrossRef

  7. 7
    R. García-Ramos, E. López Valdés, L. Ballesteros, S. Jesús, P. Mir, Informe de la Fundación del Cerebro sobre el impacto social de la enfermedad de Parkinson en España, Neurología, 2013,

    CrossRef

  8. 8
    Emilia Mabel Gatto, Virginia Parisi, Daniela Paola Converso, Juan José Poderoso, María Cecilia Carreras, José Felix Martí-Massó, Coro Paisán-Ruiz, The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics, Neuroscience Letters, 2013, 537, 1

    CrossRef

  9. 9
    David N. Cooper, Michael Krawczak, Constantin Polychronakos, Chris Tyler-Smith, Hildegard Kehrer-Sawatzki, Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease, Human Genetics, 2013, 132, 10, 1077

    CrossRef

  10. 10
    Qing Xu, Sushila Shenoy, Chenjian Li, Mouse models for LRRK2 Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S186

    CrossRef

  11. 11
    Jana Godau, Anna Hussl, Praween Lolekha, A. Jon Stoessl, Klaus Seppi, Neuroimaging: Current role in detecting pre-motor Parkinson's disease, Movement Disorders, 2012, 27, 5
  12. 12
    R. Saunders-Pullman, K. Stanley, M. San Luciano, M.J. Barrett, V. Shanker, D. Raymond, L.J. Ozelius, S.B. Bressman, Gender differences in the risk of familial parkinsonism: Beyond LRRK2?, Neuroscience Letters, 2011, 496, 2, 125

    CrossRef

  13. 13
    Zhenyu Yue, M. Lenard Lachenmayer, Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications, Movement Disorders, 2011, 26, 8
  14. 14
    Azad Kumar, Mark R. Cookson, Role of LRRK2 kinase dysfunction in Parkinson disease, Expert Reviews in Molecular Medicine, 2011, 13,

    CrossRef